Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 38.98 -0.21 (0.54%)
Previous Close $39.19    52 Week High $66.55 
Open $38.90    52 Week Low $37.82 
Day High $39.38    P/E N/A 
Day Low $38.66    EPS $0.00 
Volume 5,477,353       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 38.98 -0.21 (0.54%)
Previous Close $39.19    52 Week High $66.55 
Open $38.90    52 Week Low $37.82 
Day High $39.38    P/E N/A 
Day Low $38.66    EPS $0.00 
Volume 5,477,353